People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vyriad, Inc. | — | Biotechnology | Series B | $24.4M | $967.5M | 2019 |
Kah-Whye S. Peng, PhD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kah-Whye S. Peng, PhD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edwin M. Kania, Jr. | 1 | 4 |
| Stephen J. Russell, MD, PhD | 1 | 1 |
| James J. Hannon | 1 | 1 |
| Glen N. Barber | 1 | 1 |
| Ahryon N. Cho | 1 | 1 |
| Andrew N. Khoo | 1 | 1 |
| Nathan L. Stacy | 1 | 1 |
| Alice S. Bexon, MD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.